Correlation Between Edgewise Therapeutics and Protagonist Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Protagonist Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Protagonist Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Protagonist Therapeutics
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Edgewise and Protagonist is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Protagonist Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Protagonist Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.64 times more return on investment than Protagonist Therapeutics. However, Edgewise Therapeutics is 1.56 times less risky than Protagonist Therapeutics. It trades about -0.1 of its potential returns per unit of risk. Protagonist Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 3,404 in Edgewise Therapeutics on August 29, 2024 and sell it today you would lose (196.00) from holding Edgewise Therapeutics or give up 5.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Protagonist Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Protagonist Therapeutics |
Edgewise Therapeutics and Protagonist Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Protagonist Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.| Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Scpharmaceuticals | Edgewise Therapeutics vs. Milestone Pharmaceuticals | Edgewise Therapeutics vs. Seres Therapeutics |
| Protagonist Therapeutics vs. Eliem Therapeutics | Protagonist Therapeutics vs. Scpharmaceuticals | Protagonist Therapeutics vs. Milestone Pharmaceuticals | Protagonist Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |